Get started
Author

Yeonjung Jo

Observed names: Jo, Y.J., Jo, Yeonjung, Y. Jung Jo, Y.J. Jo
Observed institutions: Boise State University, University of Kansas, University of Washington, University of Utah, Huntsman Cancer Institute, The University of Kansas Cancer Center, University of Utah Health Care, Rocky Mountain University of Health Professions
ORCID: 0000-0002-1630-2957
Observed ORCID: 0000-0002-1630-2957
OpenAlex ID: A5022549511
Predicting Pressure Injury in Critical Care Patients: A Machine-Learning Model
2018 · Jenny Alderden, Ginette Alyce Pepper, et al. · American Journal of Critical Care · 258
The association of modifiable mechanical ventilation settings, blood gas changes and survival on extracorporeal membrane oxygenation for cardiac arrest
2022 · Joseph E. Tonna, Craig H. Selzman, et al. · Resuscitation · 55
The Association of Modifiable Postresuscitation Management and Annual Case Volume With Survival After Extracorporeal Cardiopulmonary Resuscitation
2022 · Joseph E. Tonna, Craig H. Selzman, et al. · Critical Care Explorations · 49
Trends and Disparities in Next-Generation Sequencing in Metastatic Prostate and Urothelial Cancers
2024 · Chadi Hage Chehade, Yeonjung Jo, et al. · JAMA Network Open · 41
Oral Medication Adherence Among Adolescents and Young Adults with Cancer Before and Following Use of a Smartphone-Based Medication Reminder App
2018 · Lauri A. Linder, Yelena P. Wu, et al. · Journal of Adolescent and Young Adult Oncology · 36
Treatment Patterns and Attrition With Lines of Therapy for Advanced Urothelial Carcinoma in the US
2024 · Vinay Mathew Thomas, Yeonjung Jo, et al. · JAMA Network Open · 28
A Real-World Analysis of the Use of Systemic Therapy in Malignant Pleural Mesothelioma and the Differential Impacts on Overall Survival by Practice Pattern
2022 · Kathleen Kerrigan, Yeonjung Jo, et al. · JTO Clinical and Research Reports · 26
Outdoor activities and sunburn among urban and rural families in a Western region of the US: Implications for skin cancer prevention
2022 · Yelena P. Wu, Bridget Parsons, et al. · Preventive Medicine Reports · 14
PDF
Treatment and Attrition Trends for Metastatic Clear Cell Renal Cell Carcinoma in the US
2025 · Zeynep Irem Ozay, Yeonjung Jo, et al. · JAMA Network Open · 13
Bone Pain and Survival Among Patients With Metastatic, Hormone-Sensitive Prostate Cancer
2024 · Georges Gebrael, Yeonjung Jo, et al. · JAMA Network Open · 11
Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone-sensitive Prostate Cancer: Results from SWOG S1216, a Phase 3 Randomized Trial of Androgen Deprivation Plus Orteronel or Bicalutamide
2024 · Mamta Parikh, Catherine Tangen, et al. · European Urology Oncology · 10
Race and Treatment Outcomes in Patients With Metastatic Castration-Sensitive Prostate Cancer
2023 · Nicolas Sayegh, Umang Swami, et al. · JAMA Network Open · 10
PDF
Impact of androgen receptor alterations on cell‐free DNA genomic profiling on survival outcomes in metastatic castration‐resistant prostate cancer
2023 · Nishita Tripathi, Vinay Mathew Thomas, et al. · The Prostate · 9
PDF
Objectively-Assessed Ultraviolet Radiation Exposure and Sunburn Occurrence
2023 · Tammy Stump, Suzanne Fastner, et al. · International Journal of Environmental Research and Public Health · 8
PDF
Abstract 117: Critical Care Management, Hospital Case Volume, and Survival After Extracorporeal Cardiopulmonary Resuscitation
2020 · Joseph Tonna, Craig Selzman, et al. · Circulation · 8
Changes in Central Line–Associated Bloodstream Infection Rates Among Children With Immune Compromised Conditions: An 11-Year Review
2018 · Lauri A. Linder, Cheryl Gerdy, et al. · Journal of Pediatric Oncology Nursing · 8
Genomic biomarkers of survival in patients with metastatic hormone-sensitive prostate cancer undergoing intensified androgen deprivation therapy
2025 · Georges Gebrael, Nicolas Sayegh, et al. · Prostate Cancer and Prostatic Diseases · 7
External Validation of Association of Baseline Circulating Tumor Cell Counts with Survival Outcomes in Men with Metastatic Castration-Sensitive Prostate Cancer
2022 · Umang Swami, Nicolas Sayegh, et al. · Molecular Cancer Therapeutics · 7
Genomic landscape of locally advanced or metastatic urothelial carcinoma with squamous differentiation compared to pure urothelial carcinoma
2022 · Nishita Tripathi, Yeonjung Jo, et al. · Urologic Oncology Seminars and Original Investigations · 6
Trends and Disparities in the Use of Next-Generation Sequencing in Patients With Cancer in the United States
2026 · Chadi Hage Chehade, Zeynep Irem Ozay, et al. · JAMA Network Open · 5
PDF
Effectiveness of Second-Line Cabozantinib in Metastatic Clear Cell Renal Cell Carcinoma Patients After First-Line Treatment with Immune Checkpoint Inhibitor-based Combinations
2024 · Arshit Narang, Georges Gebrael, et al. · Kidney Cancer · 5
Genomic landscape of advanced prostate cancer patients with BRCA1 versus BRCA2 mutations as detected by comprehensive genomic profiling of cell-free DNA
2022 · Umang Swami, Raquel Mae Zimmerman, et al. · Frontiers in Oncology · 5
PDF
Breastfeeding Attitudes and Practices in a Rural Utah Navajo Community
2021 · Laura L. Brown, Revina Talker, et al. · Maternal and Child Health Journal · 5
First-Line Ipilimumab with Nivolumab versus Immune Checkpoint Inhibitors with Tyrosine Kinase Inhibitors in Patients with Intermediate- or Poor-Risk Metastatic Clear Cell Renal Cell Carcinoma
2025 · Micah Ostrowski, Yeonjung Jo, et al. · Journal of Kidney Cancer and VHL · 4
PDF
Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor
2024 · Georges Gebrael, Yeonjung Jo, et al. · Cancer · 4
Works count: 124
Citation count: 671
H-index: 10
I10-index: 12
Year
Topic
Type